End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.nature.com/articles/nrd2775-c1.pdf
Reference6 articles.
1. Jones, D. End of the line for cannabinoid receptor 1 as an anti-obesity target? Nature Rev. Drug Discov. 7, 961–963 (2008).
2. Bifulco, M., Grimaldi, C., Gazzerro, P., Pisanti, S. & Santoro, A. Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. Mol. Pharmacol. 71, 1445–1456 (2007).
3. Bifulco, M., Malfitano, A. M., Pisanti, S. & Laezza, C. Endocannabinoids in endocrine and related tumours. Endocr. Relat. Cancer 15, 391–408 (2008).
4. Bianchini, F., Kaaks, R. & Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol. 3, 565–574 (2002).
5. Pisanti, S. et al. Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy. J. Cell Physiol. 211, 495–503 (2007).
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Histoire du cannabis médical;La Presse Médicale Formation;2020-10
2. Medical Cannabis : A plurimillennial history of an evergreen;Journal of Cellular Physiology;2018-11-11
3. Synthesis and molecular docking of N′-arylidene-5-(4-chlorophenyl)-1-(3,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbohydrazides as novel hypoglycemic and antioxidant dual agents;Bioorganic & Medicinal Chemistry;2016-05
4. Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists;Neuroscience;2015-09
5. Peripherally restricted CB1 receptor blockers;Bioorganic & Medicinal Chemistry Letters;2013-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3